Pharmacokinetic Properties and Tolerability of Low-dose SoluMatrix Diclofenac
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 37 (2) , 448-461
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsThe Lancet, 2013
- Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income CountriesPLOS Medicine, 2013
- A Phase 2 Study Evaluating the Efficacy and Safety of a Novel, Proprietary, Nano-Formulated, Lower Dose Oral DiclofenacPain Medicine, 2012
- Diclofenac potassium 25 mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative bioavailability study vs. diclofenac potassium 2 × 12.5 mg tabletsInt. Journal of Clinical Pharmacology and Therapeutics, 2012
- The Pharmacokinetic Parameters of a Single Dose of a Novel Nano–formulated, Lower-Dose Oral DiclofenacPostgraduate Medicine, 2012
- A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicityRheumatology International, 2011
- Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: A single-dose, randomized, two-way crossover studyClinical Therapeutics, 2009
- Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in ratsBritish Journal of Pharmacology, 2008
- Diclofenac Solubility: Independent Determination of the Intrinsic Solubility of Three Crystal FormsJournal of Medicinal Chemistry, 2007
- EFFECT OF FOOD ON THE MULTIPLE-PEAK BEHAVIOR AFTER A SINGLE ORAL DOSE OF DICLOFENAC SODIUM SLOW-RELEASE TABLET IN HUMANSAmerican Journal of Therapeutics, 1995